Identifying New Zealand Public Preferences for Pharmacist Prescribers in Primary Care: A Discrete Choice Experiment.

The Patient
Rakhee RaghunandanAlesha Smith

Abstract

Given increasing patient populations, general practitioner workforce constraints and the growing demand for health services in New Zealand (NZ), the development and provision of pharmacist prescribing services could be used to improve people's access to medicines. A discrete choice experiment (DCE) was utilised to determine NZ public preferences for pharmacist prescribing services in primary care in NZ. A D-efficient DCE design generated 20 choice questions in four blocks of five questions with three labelled alternatives per choice question. The online DCE used a NZ general public online research panel administered by an external organisation (SurveyEngine). The DCE included six attributes with two attributes each with two levels (location of consultation and consultation type), three levels (type of service and operating hours) and four levels (waiting time and cost). Nine hundred and twenty-four respondents completed the survey with 4620 observations available for analyses. Respondents preferred pharmacist prescribing services with the following characteristics: optimisation of medicines and changes to only current medicine service types (relative to repeat prescribing); lower consultation costs, shorter waiting times, longe...Continue Reading

References

Jan 22, 2000·BMJ : British Medical Journal·C PopeN Mays
Mar 25, 2008·Journal of the American Pharmacists Association : JAPhA·Jacqueline S GardnerSolmaz Shotorbani
Jul 16, 2008·PharmacoEconomics·Emily Lancsar, Jordan Louviere
Jul 29, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Kirsten Howard, Glenn Salkeld
Jan 18, 2011·The International Journal of Pharmacy Practice·Kreshnik HotiBruce Sunderland
Jun 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·John F P BridgesJosephine Mauskopf
Sep 9, 2011·The International Journal of Pharmacy Practice·Derek C StewartDorothy J McCaig
Dec 14, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Kirsten HowardIan C Roberts-Thomson
Aug 8, 2012·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Karen GerardAlesha Smith
Oct 17, 2012·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Laura M McCannCarmel M Hughes
Jan 11, 2013·The International Journal of Pharmacy Practice·Pradnya Naik-PanvelkarBandana Saini
Jan 23, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·F Reed JohnsonJohn F P Bridges
May 22, 2013·International Journal of Clinical Pharmacy·Katie MacLureDerek Stewart
Jun 25, 2013·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Michela TinelliStephen R Chapman
Apr 12, 2014·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Karen GerardAlison Blenkinsopp
Aug 15, 2014·Research in Social & Administrative Pharmacy : RSAP·Jennifer A WhittyAmanda J Wheeler
Nov 28, 2015·International Journal of Clinical Pharmacy·Caroline VassKatherine Payne
Feb 24, 2016·Research in Social & Administrative Pharmacy : RSAP·Ida-Maisie Famiyeh, Lisa McCarthy
Mar 20, 2016·Applied Health Economics and Health Policy·Axel Mühlbacher, F Reed Johnson
Jun 22, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·A Brett HauberJohn F P Bridges
Aug 6, 2016·Therapeutic Advances in Drug Safety·Louise C CopeMary P Tully
Nov 23, 2016·The Cochrane Database of Systematic Reviews·Greg WeeksDerek Stewart
Jul 13, 2017·BMC Health Services Research·Kim-Sarah KleijChristian Krauth
Nov 2, 2017·Therapeutic Advances in Drug Safety·Rakhee RaghunandanAlesha Smith
Jun 7, 2018·British Journal of Clinical Pharmacology·Tesnime JebaraDerek Stewart
May 3, 2019·Journal of Interprofessional Care·Chowdhury F FaruqueeLisa M Guirguis
Jul 20, 2019·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Yazid N Al HamarnehRoss T Tsuyuki
Aug 14, 2019·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Benjamin FletcherOliver Rivero-Arias

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
C R Talley
Revue médicale suisse
Bertrand Kiefer
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Mário L de Lemos
© 2021 Meta ULC. All rights reserved